Caregen Co (214370.KQ) Stock Price

Caregen Co Price

CLOSED
26,550.00
​
Market closed

Revenue has compounded at 11.2% per year over the past 13 years to 72.81 B KRW. Earnings per share have declined at 13.7% per year over the last 13 years. Caregen Co's net margin stands at 27.6%, down from 42.8% several years earlier. Caregen Co currently offers a dividend yield of about 1.65%. The payout ratio is around 106% of earnings. The dividend has grown at 13.8% per year over the past 10 years. Analysts set a median price target of 38,760.00 KRW, implying 46.0% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Caregen Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caregen Co business model & stock analysis

Caregen Co., Ltd. develops and sells cosmetic products under various brand names. The company manufactures HSR CEs for improving facial wrinkles and strengthening protection under Dermaheal, aquashines for skin whitening and cell activation under REVOFIL, HL CEs for hair loss treatment, hair filler excell C'rums for hair growth, LL CEs for fat decomposition, hydra B5 Gels, ultra AW500s, eye filler masks, and efficacy raw materials like growth factors and biomimetic peptides. Products are distributed domestically and internationally. Dermaheal targets consumers seeking anti-aging solutions, while REVOFIL focuses on skin whitening and renewal. HL CEs and hair filler excell C'rums cater to hair care segments, and LL CEs serve fat reduction needs. The firm's efficacy raw materials are sold to other cosmetic manufacturers for formulation development. Domestic and overseas markets purchase Caregen's products, with Dermaheal and REVOFIL being key brands for direct consumer sales. Hair and fat-related products target specific health and beauty segments, while raw materials support B2B partnerships in the cosmetic industry.

Frequently asked questions about Caregen Co

Analysts currently set an average price target of 38,760.00 KRW for the Caregen Co stock (median: 38,760.00 KRW), implying +46.0 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Caregen Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Caregen Co to generate revenue of 119.00 B KRW and earnings per share of 1,248.72 KRW.

Converted at the current exchange rate, the Caregen Co share trades at 18.18 EUR (26,550.00 KRW).

The expected revenue of Caregen Co is 119.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Caregen Co is 61.03 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Caregen Co is currently 21.26. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Caregen Co stock.

The price-to-sales ratio (P/S) of Caregen Co is currently 10.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Caregen Co stock.

The Eulerpool Quality Score for Caregen Co is 5/10.

The ISIN of Caregen Co is KR7214370009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Caregen Co is 214370.KQ. The ticker symbol is used to trade Caregen Co shares on the stock exchange.

Fair ValueTerminal
24,426.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 17, 2015
ISIN
KR7214370009
Cusip
Y1R376105
Market capitalization
1.30 T KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
21.34
P/Se
10.90
EV/EBIT
63.85
P/B Ratio
6.13
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.46 %
Dividend
Dividend yield
1.65 %
Est. Dividend Yield
1.51 %
Payout Ratio
106.26 %
Dividend growth Ø5Y
-1.02 %
Dividend payments per year
2
Dividend paid since
11 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Nov 22, 2026, 12:33 AM

Caregen Co Peer Group

Caregen Co FIGI

214370:KS · BBG00B3L62H6214370:KQ · BBG00B3L62K2

All fundamentals and in-depth analysis of Caregen Co

Our stock analysis for Caregen Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caregen Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.